Sort By

  • Newest

  • Newest

  • Oldest

  • Author Name

  • Author Name

  • David Chaplin

  • Drew Meredith

  • Giselle Roux

  • Greg Bright

  • Ishan Dan

  • James Dunn

  • Lachlan Maddock

  • Owen Raszkiewicz

Dividends, investor rights in focus amid pandemic

I’ll do my best to avoid cliches, but to say 2020 was difficult would be an understatement. There is little doubt that we are all sick of hearing terms like ‘pivot’, ‘WFH’, or ‘iso’. Yet as we emerge, hopefully, from the darkest period for worldwide health and worldwide economic uncertainty in living memory [remember there…
Drew Meredith | 15th Dec 2020 | More
ASX update; COVID-19 impacting Macquarie Group

Vaccine trial restart boosts markets, ASX strength to continue, COVID-19 impacting Macquarie Group A positive lead from Wall Street and news that AstraZeneca plc (NYSE:AZN) had resumed their vaccine trial sent the ASX 200 (ASX:XJO) 0.7% higher on Monday. Positive news on the vaccine front support the energy and industrial sectors amid hope of a…
Drew Meredith | 14th Sep 2020 | More
ASX shares update; markets look past recession to the future

Turnaround: markets look past recession to the future, AMP in hot demand, another positive lead ahead The ASX 200 (ASX:XJO) staged a remarkable recovery, adding 1.8% even as we received confirmation that the economy had contracted by 7% in the June quarter. The rally was broad-based with industrials and materials improving on the back of…
Drew Meredith | 4th Sep 2020 | More
    • Market update – Federal Reserve loosens inflation reins

    It was a mixed day for the market, the ASX 200 (ASX:XJO) finished 0.2% higher despite trading up as much as 0.8% during the day.
    Drew Meredith | 27th Aug 2020 | More